Return to homepagePandemic Pact

CoroNAT: Coronavirus therapeutic neutralising antibodies

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $1,094,501.6

  • Funder

    UFM Denmark

  • Principal Investigator

    Senior Lecturer Martin Tolstrup

  • Research Location

    Denmark

  • Lead Research Institution

    Aarhus University Hospital, Aarhus University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This project will investigate the development of therapeutic neutralising antibodies in people infected with SARS-CoV-2. In particular, the study will investigate if all those infected, whether their infection be serious, mild or not evident, produce neutralising antibodies. In particular, the project will isolate and identify the best neutralising antibodies, in order to investigate whether these antibodies can be used in treatment, or how such antibodies may be induced by some future vaccination.